Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose placebo-controlled study of Strepsils Plus and Strepsils Extra for sore throat due to upper respiratory tract infection
2010-024045-69Phase 4Completed
- Sponsor
- Reckitt
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Strepsils Max Plus, Hexylresorcinol and Placebo-COD Research Private Ltd in upper respiratory infection (URI) (3 arms), sponsored by Reckitt. Primary endpoint: Change from baseline in throat soreness at 2 hours post-dose. Started Dec 2010; status: completed.
02
Drugs
Strepsils Max PlusHexylresorcinolPlacebo-COD Research Private Ltd
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on 2010-024045-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024045-69.